Permixon

/ Padagis Israel Agencies Ltd

2 capsules a day at mealtimes, should be taken with a glass of water.

Treatment of moderate micturition troubles related to benign hypertrophy of prostate in adult men.

Hypersensitivity to one of the components; Pre-existing serious abdominal disorders.

In accordance with the routine monitoring of benign prostatic hypertrophy, the patient must be under ongoing medical supervision during treatment.
Taking this medicinal product on empty stomach may cause nausea.

Common: Headaches, abdominal pain.
See prescribing information for full details .

Experimental studies with PERMIXON do not show any negative interference with the therapeutic groups commonly associated with this condition (antibiotics for urinary tract infections, antiseptics and anti-inflammatory medicines).
Results from dedicated in vitro studies demonstrated the absence of inhibition and induction potential of lipidosterolic extract of Serenoa repens.
No pharmacokinetic interactions are expected with co-administered treatments.

Not applicable, as this medicinal product is not indicated in women.

In the event of overdose, gastrointestinal disorders may occur.

Store below 25◦C.